✦ LIBER ✦

T cell-mediated inhibition of erythropoiesis in myelodysplastic syndromes

✍ Scribed by Tomohiro Sugawara; Kazuyasu Endo; Tomoaki Shishido; Akiyoshi Sato; Junichi Kameoka; Osamu Fukuhara; Kaoru Yoshinaga; Akira Miura

Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 226 KB
Volume: 41
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830410425

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Absence of immunoglobulin and T-cell rec

Absence of immunoglobulin and T-cell receptor gene rearrangements in myelodysplastic syndromes and acute nonlymphocytic leukemias

✍ J. S. Wainscoat; M. F. Fey; S. Pilkington; C. Summers; D. G. Oscier 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB 👁 2 views

Inhibition of T-cell responses by hepati

Inhibition of T-cell responses by hepatic stellate cells via B7-H1–mediated T-cell apoptosis in mice

✍ Ming-Chin Yu; Cheng-Hsu Chen; Xiaoyan Liang; Lianfu Wang; Chandrashekhar R. Gand 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 450 KB 👁 1 views

Mechanisms of erythropoiesis inhibition

Mechanisms of erythropoiesis inhibition by malarial pigment and malaria-induced proinflammatory mediators in an in vitro model

✍ Gordon A. Awandare; Prakasha Kempaiah; Daniel O. Ochiel; Paolo Piazza; Christoph 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 652 KB

Red blood cell transfusions and iron ove

Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes

✍ Elias Jabbour; Hagop M. Kantarjian; Charles Koller; Ali Taher 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 2 views

## Abstract ## BACKGROUND Approximately 15,000 new cases of myelodysplastic syndromes (MDS) are expected in the United States each year. ## METHODS The mainstay for the management of myelodysplastic syndromes (MDS) is supportive therapy with red blood cell (RBC) transfusions to improve the patie

Hyperfibrinolysis in a case of myelodysp

Hyperfibrinolysis in a case of myelodysplastic syndrome with leukemic spread of mast cells

✍ Wimazal, F.; Sperr, W.R.; Horny, H.-P.; Carroll, V.; Binder, B.R.; Fonatsch, C.; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB 👁 2 views

Mast cells (MC) are multipotent hemopoietic effector cells producing diverse mediators like histamine, heparin, or tissue type plasminogen activator. We report a 75-year-old male patient with myelodysplastic syndrome (MDS) of recent onset (3 months' history) associated with a massive leukemic spread

Pure red cell aplasia complicated by ang

Pure red cell aplasia complicated by angioimmunoblastic T-cell lymphoma: Humoral factor plays a main role in the inhibition of erythropoiesis from CD34+ progenitor cells

✍ Tsujimura, Hideki; Sakai, Chikara; Takagi, Toshiyuki 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB 👁 2 views

Forming Assay From CD34 + Bone Marrow Cells Serum a BFU-E/10 2 CD34 + cells Control 1 50.2 ± 4.6 Control 2 48.5 ± 14.1 Before chemotherapy 24.4 ± 6.2 b After chemotherapy 50.5 ± 6.5 Values are means ± SD of triplicate cultures. a Control 1; normal AB serum, Control 2; serum from a patient with AILD-